Americas Silver (USAS) had the highest return in 2019 by a small-cap US stock, returning 720,354.5%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Americas Silver (USAS) | 2019 | 720,354.55% |
InnovAge (INNV) | 2019 | 1,375.95% |
Relmada Therapeutics (RLMD) | 2019 | 747.83% |
EverQuote Inc Class A (EVER) | 2019 | 725.72% |
Neurogene (NGNE) | 2019 | 473.02% |
Pennant (PNTG) | 2019 | 437.72% |
MiMedx (MDXG) | 2019 | 345.88% |
Ardelyx (ARDX) | 2019 | 341.47% |
New Pacific Metals (NEWP) | 2019 | 321.1% |
Fulgent Genetics (FLGT) | 2019 | 306.94% |
Digital Turbine (APPS) | 2019 | 285.41% |
Aspen Aerogels (ASPN) | 2019 | 264.32% |
Borr Drilling (BORR) | 2019 | 254.9% |
Arvinas (ARVN) | 2019 | 224.82% |
Iovance Biotherapeutics (IOVA) | 2019 | 215.62% |
Alphatec (ATEC) | 2019 | 213.94% |
Zymeworks Inc Common Stock (ZYME) | 2019 | 203.07% |
Red Violet (RDVT) | 2019 | 202.45% |
Santacruz Silver Mining Ltd Common Shares (SCZM) | 2019 | 202.14% |
Ballard Power Systems (BLDP) | 2019 | 193.06% |
Clearpoint Neuro (CLPT) | 2019 | 192.68% |
InMode (INMD) | 2019 | 190.37% |
Envela (ELA) | 2019 | 187.23% |
Paysign (PAYS) | 2019 | 185.92% |
Osisko Development (ODV) | 2019 | 176% |
Small-cap stocks are treated as having a market cap between $300M and $2B.